Curated News
By: NewsRamp Editorial Staff
March 05, 2026
Lionheart Health Appoints Neurosurgery Pioneer Dr. Joseph Maroon to Advisory Board
TLDR
- Lionheart Health gains a strategic edge by adding renowned neurosurgeon Dr. Joseph Maroon to its advisory board, enhancing credibility for its brain health and longevity technologies.
- Dr. Maroon will advise Lionheart Health on clinical study design and protocol translation for bioelectric therapies targeting neuroplasticity, inflammation reduction, and regenerative protein expression.
- This collaboration aims to advance therapies that improve cognition and reduce neuroinflammation, potentially extending meaningful healthspan and enhancing quality of life during aging.
- The Pittsburgh Steelers' team neurosurgeon, an expert in concussion management and longevity science, is now guiding bioelectric stimulation technology for brain health.
Impact - Why it Matters
This appointment represents a significant convergence of clinical neuroscience and emerging bioelectric medicine technologies. Dr. Maroon's four decades of experience in neurosurgery, concussion management, and longevity science brings crucial clinical validation to Lionheart Health's approach. As populations age globally, cognitive decline and neurodegenerative conditions represent growing public health challenges. Bioelectric stimulation therapies that can demonstrably improve brain function, reduce inflammation, and support neuroplasticity could potentially offer non-invasive alternatives or complements to pharmaceutical interventions. The collaboration between a respected neurosurgeon and a company developing targeted bioelectric technologies may accelerate the translation of regenerative science into practical clinical applications, potentially benefiting millions dealing with age-related cognitive changes, concussion recovery, or seeking to optimize brain health throughout their lifespan.
Summary
Lionheart Health, Inc., a pioneering company in bioelectric regenerative medicine and healthspan optimization, has significantly strengthened its scientific leadership by appointing Dr. Joseph C. Maroon to its Scientific and Clinical Advisory Board. Dr. Maroon, a board-certified neurosurgeon, Clinical Professor at the University of Pittsburgh Medical Center (UPMC), and longtime Team Neurosurgeon for the Pittsburgh Steelers, brings over four decades of expertise in brain health, sports neurosurgery, concussion management, neuroinflammation, and longevity science. His appointment reinforces Lionheart Health's commitment to advancing evidence-based bioelectric stimulation therapies designed to improve cognition, memory, mood, support neuroplasticity, reduce inflammation, and enhance regenerative protein expression linked to healthy aging.
The company's multi-modality platform, including patented technologies like BodStim™ and Brain Band™, aligns closely with Dr. Maroon's focus on neuroprotection and performance longevity. Dr. Maroon will advise on brain health clinical study design, neurocognitive endpoint validation, concussion applications, and integrating lifestyle strategies with bioelectric therapies. Lionheart Health is actively advancing clinical initiatives targeting functional biomarkers of aging and holds an expanding intellectual property portfolio targeting key regenerative pathways such as Klotho, BDNF, and GDF10. The company is competing in the Semi-Finals of the $101M XPRIZE Healthspan Competition and has received recognition including the 2025 Micro Stimulator Developer of the Year award from Medtech Outlook Magazine.
Howard Leonhardt, Founder and Executive Chairman of Lionheart Health, emphasized that Dr. Maroon's leadership brings exceptional scientific credibility to their mission of increasing healthspan through measurable improvements in muscle, brain, and immune function. Dr. Maroon expressed his enthusiasm for supporting innovative bioelectric therapies that aim to improve neurological resilience and enhance overall vitality. With successful pre-clinical studies and a pilot clinical study in Brazil completed, Lionheart Health is preparing to enroll participants in a combination BodStim™ and Brain Band™ clinical trial, building on previous studies that demonstrated statistically significant improvements in brain health. The company operates licensed longevity clinics and collaborates with academic institutions to generate peer-reviewed data supporting its therapies.
Source Statement
This curated news summary relied on content disributed by Newsworthy.ai. Read the original source here, Lionheart Health Appoints Neurosurgery Pioneer Dr. Joseph Maroon to Advisory Board
